Additional file 2: of Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Figure S1. Kaplan-Maier OS and PFS curves of melanoma patient treated with nivolumab. (A) Patients stratified according baseline median ANC as cutoff . Green line: ANC≥5.4; Blue line: ANC<5.4. (B) Patients stratified for PFS according baseline median ANC as cut-off . Green line: ANC≥5.4; Blue line: ANC<5.4. Figure S2. Kaplan-Maier OS and PFS curves of melanoma patient treated with nivolumab using optimal cutoff for derived neutrophils-to lymphocyte ratio (dNLR). (A)) Patients stratified according baseline dNLR. Green line: dNLR≥3.8; Blue line: dNLR<3.8. (DOCX 168 kb

Additional file 1: of Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Table S1A. Cox regression models on overall survival in patients with brain metastases (DOCX 15 kb